General Information of the Compound
| Compound ID |
CP0433706
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
2,6-diphenylpyrimidin-4-amine
Show/Hide
|
||||||||||||||||||
| Synonyms |
(2,6-diphenyl-pyrimidin-4-yl)-amine
2,6-Diphenyl-4-pyrimidinamine
2,6-Diphenyl-4-pyrimidinamine #
2,6-Diphenyl-pyrimidin-4-ylamine
2,6-diphenylpyrimidin-4-amine
4-Amino-2,6-diphenylpyrimidine
AC1LDIB7
AKOS011055092
BDBM50375487
CHEMBL406788
PLXFRDQUOPPVHF-UHFFFAOYSA-N
SCHEMBL1490059
ZINC29062470
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C16H13N3
|
||||||||||||||||||
| Molecular Weight |
247.301
|
||||||||||||||||||
| Canonical SMILES |
Nc1cc(nc(n1)-c1ccccc1)-c1ccccc1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C16H13N3/c17-15-11-14(12-7-3-1-4-8-12)18-16(19-15)13-9-5-2-6-10-13/h1-11H,(H2,17,18,19)
Show/Hide
|
||||||||||||||||||
| InChIKey |
PLXFRDQUOPPVHF-UHFFFAOYSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT00840, Adenosine receptor A1
Protein ID: PT00862, Adenosine receptor A2a
Clinical Information about the Compound